BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24316259)

  • 1. Artemisinins: pharmacological actions beyond anti-malarial.
    Ho WE; Peh HY; Chan TK; Wong WS
    Pharmacol Ther; 2014 Apr; 142(1):126-39. PubMed ID: 24316259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
    Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
    Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.
    Chaturvedi D; Goswami A; Saikia PP; Barua NC; Rao PG
    Chem Soc Rev; 2010 Feb; 39(2):435-54. PubMed ID: 20111769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent pharmacological advances in the repurposing of artemisinin drugs.
    Meng Y; Ma N; Lyu H; Wong YK; Zhang X; Zhu Y; Gao P; Sun P; Song Y; Lin L; Wang J
    Med Res Rev; 2021 Nov; 41(6):3156-3181. PubMed ID: 34148245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.
    Cheong DHJ; Tan DWS; Wong FWS; Tran T
    Pharmacol Res; 2020 Aug; 158():104901. PubMed ID: 32405226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential applications of artemisinins in ocular diseases.
    Lu BW; Xie LK
    Int J Ophthalmol; 2019; 12(11):1793-1800. PubMed ID: 31741871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities.
    Sun C; Cao Y; Zhu P; Zhou B
    Sci Rep; 2017 Apr; 7():45665. PubMed ID: 28368011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
    Nakase I; Lai H; Singh NP; Sasaki T
    Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Activities of Artemisinin Derivatives Beyond Malaria.
    Liu X; Cao J; Huang G; Zhao Q; Shen J
    Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate.
    Tsuda K; Miyamoto L; Hamano S; Morimoto Y; Kangawa Y; Fukue C; Kagawa Y; Horinouchi Y; Xu W; Ikeda Y; Tamaki T; Tsuchiya K
    Biol Pharm Bull; 2018; 41(4):555-563. PubMed ID: 29607928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
    Kim JH; Choi AR; Kim YK; Yoon S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Activity of Artemisinin and its Derivatives.
    Slezakova S; Ruda-Kucerova J
    Anticancer Res; 2017 Nov; 37(11):5995-6003. PubMed ID: 29061778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases.
    Gao X; Lin X; Wang Q; Chen J
    Med Res Rev; 2024 Mar; 44(2):867-891. PubMed ID: 38054758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.
    Jung M; Lee K; Kim H; Park M
    Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin and its derivatives in treating protozoan infections beyond malaria.
    Loo CS; Lam NS; Yu D; Su XZ; Lu F
    Pharmacol Res; 2017 Mar; 117():192-217. PubMed ID: 27867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production.
    Pandey N; Pandey-Rai S
    Protoplasma; 2016 Jan; 253(1):15-30. PubMed ID: 25813833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral activities of artemisinin and artesunate.
    Efferth T; Romero MR; Wolf DG; Stamminger T; Marin JJ; Marschall M
    Clin Infect Dis; 2008 Sep; 47(6):804-11. PubMed ID: 18699744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinins: their growing importance in medicine.
    Krishna S; Bustamante L; Haynes RK; Staines HM
    Trends Pharmacol Sci; 2008 Oct; 29(10):520-7. PubMed ID: 18752857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
    Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
    Sante; 2011; 21(3):133-42. PubMed ID: 22294247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.